Interv Akut Kardiol. 2006;5(4):157-162

TREATMENT OF ACUTE PULMONARY EMBOLISM IN LOCAL HOSPITAL

Margita Belicová, Marian Mokáň
I. Interná klinika MFN Martin

We are introducing retrospective analysis of treatment of 229 patients with acute pulmonary embolism (PE), representing 0.83 % of all 27 747 patients who were hospitalized in our clinic between 1996 and 2005.

Aim: We concentrated on thrombolytic treatment (TT) especially in patients with acute non massive PE and right ventricular dysfunction (RVD).

Study group and methods: Out of 229 patients (119 women) 42 patients had massive PE, 184 patients had non massive PE and 103 of them RVD on baseline echocardiography and 3 patients had chronic thromboembolic pulmonary hypertension. 73 patients were treated with thrombolysis (32 patients with massive PE and 41 patients with non massive PE and RVD) and 156 patients were treated with heparin alone. Based on hospital mortality rate in patients with non massive PE and RVD we evaluated TT compared to heparin alone. We evaluated also the role of assessment troponin T before initiation of treatment.

Results: Hospital mortality rate of patients with massive PE, who were treated with thrombolysis was 56 %. While we compared hospital mortality rate of patient with non massive PE and RVD, who were treated with thrombolysis or with heparin alone, patients, who were treated with thrombolysis had lower hospital mortality rate than patients, who were treated with heparin alone (2,4 % vs. 13 %, p = 0,06). If we decided to treat with heparin according to clinical severity without examination of troponin T compare to patients when we decide for this treatment because of negative troponin T and compared hospital mortality rate in both groups, we did not find out any significant difference (11 % vs. 20 %, p = 0,34).

Conclusions: TT is the way to save life of patients with massive PE. Efect of treatment with heparin alone in patients with non massive PE and RVD and negative troponin T is insufficient. Patients with non massive PE and RVD and negative troponin T require also often TT.

Keywords: Key words: pulmonary embolism, right ventricular dysfunction, thrombolysis, heparin.

Published: February 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Belicová M, Mokáň M. TREATMENT OF ACUTE PULMONARY EMBOLISM IN LOCAL HOSPITAL. Interv Akut Kardiol. 2006;5(4):157-162.
Download citation

References

  1. Arcasoy S, Kreit JW. Thrombolytic therapy of pulmonary embolism. A comprehensive review of current evidence. Chest 1999; 115: 1695-1707. Go to original source... Go to PubMed...
  2. Goldhaber S. Contemporary pulmonary embolism thrombolysis. Chest 1995; 107: 45S-51S. Go to original source... Go to PubMed...
  3. Task Force Report. Task Force on Pulmonary Embolism. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000; 21: 1301-1336. Go to original source... Go to PubMed...
  4. Grifoni S, Olivotto I, Cecchinz P et al. Schort-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure and echocardiographic right ventricular dysfunction. Circulation 2000; 101: 2817-2722. Go to original source... Go to PubMed...
  5. Riedel M, Widimský J, Susa Z, a spol. Plicní embolie. In: Aschermann M. Kardiologie. Praha: Galén 2004: 947-1009.
  6. Widimský J, Malý J a spol. Akutní plicní embolie a žilní tromboza. Triton Praha 2002: 303s.
  7. Widimský J. Trombolytická léčba i u normotenzních nemocných, hemodynamicky stabilních s akutní plicní embolií? Komentář... Interv Akut Kardiol 2005; 4: 66-68.
  8. Levine MN, Rascob G, Landefeld S et al. Hemorhagic complications of anticoagulant treatment. Chest 2001; 119: 108S-121S. Go to original source... Go to PubMed...
  9. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389. Go to original source... Go to PubMed...
  10. Meneveau N, Ming LP, Séronde MF et al. In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy. Eur Heart J 2003; 24: 1447-1454.
  11. Konstantinides S, Geibel A, Olschewski M et al. Association between thrombolytic treatment and the prognosis of hemodymically stable patients with major pulmonary embolism. Results of multicenter registry. Circulation 1997; 96: 882-888. Go to original source... Go to PubMed...
  12. Goldhaber SZ. Thrombolysis for pulmonary embolism. Editorial. N Engl J Med 2002; 347: 1131-1132. Go to original source... Go to PubMed...
  13. Konstantinides S, Geibel A, Olschewski M et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circutation 2003; 106: 1263-1268. Go to original source... Go to PubMed...
  14. Janata K, Holzer M, Laggner AN et al. Cardiac troponin T in the severity assessment of patient with pulmonary embolism: cohort study. Br Med J 2003; 326: 312-313. Go to original source... Go to PubMed...
  15. Pruszcyk P, Bochowicz A, Torbicki A et al. Cardiac troponin T monitoring identifies hight-risk group of normotensive patienst with acute pulmonary embolism. Chest 2003; 123: 1947-1952. Go to original source... Go to PubMed...
  16. Kucher N, Luder CM, Dornhofer S et al. Novel management strategy for patients with suspected pulmonary embolism. Eur Heart J 2003; 24: 366-376. Go to original source... Go to PubMed...
  17. Kostrubiec M, Pruszczyk P, Bochowicz A et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J 2005; 26: 2166-2172. Go to original source... Go to PubMed...
  18. Meneveau N, Schiele F, Metz D et al. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute pulmonary embolism: Immediate clinical and hemodynamic outcome and one-year follow-up. J Am Col Cardiol 1998; 31: 1957-1063. Go to original source... Go to PubMed...
  19. Dalen JE, Alpert JB, Hirsh J. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Arch Intern Med 1997; 157: 2550-2556. Go to original source...
  20. Hyers TM, Agnelli G, Hull RD et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001, 119: 176-193. Go to original source... Go to PubMed...
  21. Žáková D. Trombolytická léčba akutní submasivní plicní embolie. Interv Akut Kardiol 2005; 4: 115-118.
  22. Jurkovičová O. Trombolytická liečba pľúcnej embolie. Cardiol 2002; 5: 296-301.




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.